Cargando…
High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
BACKGROUND/AIMS: Ribonucleotide reductase subunit M2 (RRM2) catalyzes the production of deoxynucleotide triphosphates, which are necessary for DNA synthesis. RRM2 has been reported to play an active role in tumor progression, and elevated RRM2 levels have been correlated with poor prognosis for colo...
Autores principales: | Lee, Boin, Ha, Sang Yun, Song, Dae Hyun, Lee, Hyun Woo, Cho, Soo Youn, Park, Cheol-Keun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gut and Liver
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215454/ https://www.ncbi.nlm.nih.gov/pubmed/25368754 http://dx.doi.org/10.5009/gnl13392 |
Ejemplares similares
-
High Expression of Aldo-Keto Reductase 1B10 Is an Independent Predictor of Favorable Prognosis in Patients with Hepatocellular Carcinoma
por: Ha, Sang Yun, et al.
Publicado: (2014) -
Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy
por: Wijerathna, Sanath R., et al.
Publicado: (2011) -
Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer
por: Yin, Xin, et al.
Publicado: (2023) -
Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse
por: Brown, Anthony, et al.
Publicado: (2023) -
Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
por: Kim, Hee Yeon, et al.
Publicado: (2014)